Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Botanix Pharma

Botanix Pharma
2015 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
BOT STOCK SYMBOL
$0.06 SHARE PRICE (As of Friday Closing)
Description

Botanix Pharmaceuticals Ltd is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne.

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
ASX
Primary Office
  • PO Box 1407
  • Subiaco, Western Australia 6904
  • Australia

+61 (08) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Botanix Pharma’s full profile, request a free trial.

Botanix Pharma Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.05 - $0.20 $44.7M $0.06 2.59M 774M

Botanix Pharma Financials Summary

In Thousands,
USD
TTM
31-Dec-2019
FY 2019
30-Jun-2019
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
Enterprise Value 41,140 85,950 42,134 13,550
EBITDA (12,264) (8,596) (3,630)
Net Income (12,183) (8,530) (3,597)
Total Assets 3,642 13,010 4,540
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Botanix Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Botanix Pharma‘s full profile, request access.

Request full access to PitchBook

Botanix Pharma Executive Team (5)

Name Title Board
Seat
Contact
Info
Richard Peterson Chief Financial Officer
Michael Thurn Ph.D Chief Operating Officer
H. William Bosch Executive Director & Chief Scientific Officer
Howie McKibbon Chief Commercial Officer
Stephane Levy Chief Medical Officer